tridemorph has been researched along with Breast Neoplasms, Male in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anton-Culver, H; Cantillep, AS; Carpenter, PM; Markham, EM; Yan, R; Ziogas, A | 1 |
| Arain, A; Chae, SW; Kwon, SY; Wilczynski, SP | 1 |
1 trial(s) available for tridemorph and Breast Neoplasms, Male
| Article | Year |
|---|---|
Laminin 332 expression in breast carcinoma.
Topics: Biopsy; Breast Neoplasms; Breast Neoplasms, Male; Cell Adhesion Molecules; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kalinin; Keratin-5; Keratin-6; Male; Neoplasm Invasiveness; Transcription Factors; Tumor Suppressor Proteins | 2012 |
1 other study(ies) available for tridemorph and Breast Neoplasms, Male
| Article | Year |
|---|---|
Laminin 332 expression and prognosis in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms, Male; Carcinoma; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Female; Gene Expression Regulation, Neoplastic; Humans; Kalinin; Male; Middle Aged; Neoplasm Invasiveness; Phenotype; Prognosis; Signal Transduction; Time Factors; Triple Negative Breast Neoplasms | 2018 |